Mutations in c-KIT result in SCF-independent activation of downstream signaling pathways associated with increased proliferation and cell survival, mostly found in leukemia, gastrointestinal stromal tumors (GIST), testicular germ cell tumor (TGCT) and melanoma. Here, KIT is linked to gastrointestinal stromal tumor.